DEF: Bolt Projects Holdings Seeks Critical Shareholder Approval for Dilutive Capital Raises Amid Going Concern Warning

Bolt Projects Holdings, Inc. is convening its 2025 Annual Meeting to secure shareholder approval for significant dilutive stock issuances, crucial for addressing working capital needs and mitigating a stated 'going concern' risk.

Summary

• The 2025 Annual Meeting of Stockholders for Bolt Projects Holdings, Inc. will be held virtually on Friday, August 29, 2025, at 11:00 a.m., Eastern Time.
• Key proposals include the election of Daniel Widmaier, David Breslauer, and Jeri Finard as Class I directors, and the ratification of Elliott Davis, PLLC as the independent registered public accounting firm for 2025.
• Shareholders are asked to approve the 'Seneca Issuance Proposal' for the issuance of common stock to Southern Point Capital, involving up to $3.0 million of outstanding vendor payables exchanged for common stock at a 23% discount.
• Shareholders are also asked to approve the 'Ascent Issuance Proposal' for the issuance of common stock upon conversion of convertible preferred stock and exercise of warrants to Ascent Partners Fund LLC, raising $1.2 million in gross proceeds, and under a related equity line of credit agreement for up to an aggregate of $20 million.
• The company explicitly states that the inability to procure proceeds from the Ascent Issuance Proposal 'may impair our ability to continue as a going concern'.
• A 1-for-20 reverse stock split of common stock was effected on April 21, 2025.
• The company has an approximate $2.9 million excise tax liability, with the Golden Arrow Sponsor LLC agreeing to provide or organize $10 million in financing by August 13, 2025, or pay 75% of the liability under certain conditions.
• Audit fees for Elliott Davis, PLLC were $960,000 for the year ended December 31, 2024, a decrease from $1,550,000 in 2023.
• As of July 3, 2025, there were 2,061,779 shares of common stock issued and outstanding.
• Executive compensation for 2024 included Daniel Widmaier at $3,699,979, David Breslauer at $3,467,994, and Cintia Nardi at $475,506.

Sentiment

Score: 3

Explanation: The company is in a precarious financial position, explicitly stating a 'going concern' risk if critical capital raises are not approved. The proposed financing, while necessary, is highly dilutive and indicates a need for survival capital rather than growth investment. This suggests significant underlying operational challenges.

Positives

• The company is actively seeking shareholder approval for critical financing transactions, demonstrating adherence to Nasdaq listing rules.
• The proposed capital raises (Seneca and Ascent Issuances) are intended to support general working capital needs and enhance liquidity, which is vital for the company's operations.
• The Board of Directors exhibits diverse expertise, including financial, biotechnology, consumer products, and global supply chain management backgrounds.
• Robust corporate governance policies are in place, including a Code of Business Conduct and Ethics, Insider Trading Policy, Anti-Hedging Policy, and a Clawback Policy for erroneously awarded compensation.
• The Audit Committee includes members who qualify as audit committee financial experts, indicating strong financial oversight capabilities.

Negatives

• The company requires significant capital raises to meet 'general working capital needs', indicating ongoing operational cash burn and financial strain.
• The explicit statement that the 'inability to procure the proceeds described in the Convertible Preferred Stock Offering and under the ELOC Agreement may impair our ability to continue as a going concern' highlights severe financial distress.
• The proposed stock issuances (Seneca and Ascent) will result in substantial dilution for existing stockholders, impacting their ownership percentage and voting power.
• Future sales of shares issued to Southern Point Capital and Ascent Partners Fund LLC could adversely affect the prevailing market price of the company's common stock or increase its volatility.
• The company has an outstanding excise tax liability of approximately $2.9 million, which requires a payment plan or significant financing.
• Several executive officers and the Golden Arrow Sponsor, LLC had late Section 16(a) filings, indicating potential compliance issues.
• The weighted-average exercise price of outstanding options is $262.20, significantly higher than the recent stock price of $6.80 (as of November 25, 2024), suggesting many options are underwater and may not incentivize retention or performance effectively.

Risks

• Significant dilution of existing stockholders' ownership and voting power due to the issuance of a maximum number of common shares under the Seneca and Ascent Issuance Proposals.
• Potential decline in the company's stock price or increased price volatility resulting from the future sale of shares issued to Southern Point Capital and Ascent Partners Fund LLC.
• Risk of the company's inability to continue as a going concern if the Ascent Issuance Proposal is not approved, preventing the receipt of crucial financing proceeds.
• Continued liability for outstanding Vendor Payables, which would adversely affect liquidity, if the Seneca Issuance Proposal is not approved.
• The Seneca and Ascent transactions are subject to the finalization of definitive documentation, introducing uncertainty regarding their consummation.
• Nasdaq may aggregate separate transactions for listing rule compliance, potentially restricting the company's ability to raise additional capital in the future.
• Uncertainty surrounding IRS approval of the proposed payment plan for the $2.9 million excise tax liability.
• The Ascent Convertible Preferred Stock terms include a 'Trigger Event' (e.g., Nasdaq non-compliance or VWAP below $1.00) that would increase dividends to 24.0% per annum and allow conversion at a discount, further diluting shareholders.
• The company relies on the Golden Arrow Sponsor LLC to provide or organize $10 million in financing by August 13, 2025, which is not guaranteed.

Future Outlook

The company expects to finalize and enter into agreements with Southern Point Capital and Ascent Partners Fund LLC to secure critical financing for general working capital needs. It plans to file registration statements for the resale of shares issued under the Ascent agreements within 30 days of closing and aims for effectiveness within 60 days. The Equity Line of Credit Agreement with Ascent is expected to last for 36 months, with the company retaining the right to terminate it earlier without penalty. The Compensation Committee anticipates granting annual equity incentive awards during the first quarter of each fiscal year.

Management Comments

• "Your vote is important to us. Please act as soon as possible to vote your shares." Daniel Widmaier, Chief Executive Officer and Chair of the Board.
• "On behalf of the Board of Directors and management, it is my pleasure to express our appreciation for your continued support." Daniel Widmaier, Chief Executive Officer and Chair of the Board.
• "The Board and the management of the Company believe that the potential to issue shares of Common Stock under the Seneca Transaction would result in greater liquidity for the Company and, thereby, flexibility in how it implements its business plans and ultimately generates value for its stockholders."
• "Inability to procure the proceeds described in the Convertible Preferred Stock Offering and under the ELOC Agreement may impair our ability to continue as a going concern."
• "The Board believes that, if the Annual Meeting is convened and a quorum is present, but there are not sufficient votes at that time to approve the Seneca Issuance Proposal and/or the Ascent Issuance Proposal, it is in the best interests of the stockholders to enable the Board to continue to seek to obtain a sufficient number of additional votes to approve the Seneca Issuance Proposal and/or the Ascent Issuance Proposal, as applicable."

Industry Context

Bolt Projects Holdings, Inc., having recently completed a business combination with Bolt Threads, Inc., operates in the innovative sustainable materials sector, which often requires substantial capital for research, development, and scaling production. The company's urgent need for significant capital raises to support 'general working capital needs' and the explicit 'going concern' warning suggest it is facing common challenges for growth-stage companies in capital-intensive industries, particularly those focused on developing and commercializing new technologies like bio-engineered materials (Mylo, b-silk). The involvement of directors with backgrounds in biotechnology, consumer products, and supply chain management aligns with the company's focus on bringing sustainable materials to market within the beauty and personal care industries.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or financial benchmarks to assess the company's results against broader industry standards.
• The terms of the proposed capital raises, such as the 23% discount for the Seneca issuance and the potential for conversion at 95% of the lowest daily VWAP for Ascent, reflect the company's specific financial needs and market conditions rather than a direct comparison to industry-standard financing terms.

Management Changes

Corporate Governance

Related Party Transactions

• **Settlement Agreement and Exchange Agreement with Golden Arrow Sponsor, LLC**: Entered on February 14, 2025, addressing an approximate $2.9 million excise tax liability. The Sponsor agreed to provide or organize $10 million in financing by August 13, 2025, or pay 75% of the liability under certain conditions. Additionally, 250,000 Private Placement Warrants held by the Sponsor were exchanged for a Settlement Warrant to purchase 250,000 shares of Common Stock at an exercise price of $10.00 per share.
• **Amended and Restated Registration Rights and Lock-up Agreement**: Entered into at the Closing of the Business Combination, involving the Sponsor, former GAMC directors and officers, Bolt Threads directors and officers, and certain Bolt Threads stockholders. This agreement registers for resale certain shares and includes customary demand and piggyback registration rights. Lock-up restrictions on certain shares ended on February 14, 2025.
• **Sponsor Subscription Agreement**: On October 4, 2023, the Sponsor agreed to purchase GAMC Class A common stock, later amended to reduce commitments in exchange for the Sponsor purchasing $10 million in Convertible Notes.
• **Note Purchase Agreement (October 4, 2023)**: Bolt Threads issued Convertible Notes in an aggregate principal amount of $29.6 million and Bridge Warrants to certain investors, including Golden Arrow Sponsor, LLC ($10 million), entities affiliated with Foundation Capital ($1,259,021), Anderson Investments Pte. Ltd. ($5,817,843), Scottish Mortgage Investment Trust PLC ($3,849,632), Formation8 Partners Fund I, L.P. ($2,007,845), entities affiliated with Top Tier ($2,500,000), and Jerry Fiddler ($500,000).
• **Ginkgo Note Purchase Agreement Amendments**: On December 29, 2023, and April 2024, Bolt Threads amended its Senior Secured Notes held by Ginkgo Bioworks, Inc. The modifications included converting $10.0 million of outstanding principal into a convertible note and extending the maturity date of the remaining $11.8 million (now $12.5 million outstanding as of June 30, 2024) to December 31, 2027, with a 12.00% interest rate.
• **Securities Purchase Agreement (November 25, 2024)**: The company sold an aggregate of 52,938 shares of its Common Stock for approximately $360,000 to Daniel Widmaier, David Breslauer, Randy Befumo, Jeri Finard, and an entity affiliated with Jerry Fiddler, at a purchase price of $6.80 per share.

Stakeholder Impact

• **Shareholders**: Will experience significant dilution of their ownership interests and voting power if the proposed Seneca and Ascent Issuance Proposals are approved. The potential for future sales of newly issued shares could also negatively impact the stock price. Shareholders are being asked to vote on critical proposals that directly affect the company's financial viability.
• **Vendors**: The Seneca Transaction, if approved, aims to address up to $3.0 million in outstanding vendor payables, which could improve relationships and the company's standing with its suppliers.
• **Employees/Management**: Executive officers and directors are subject to new corporate governance policies, including a clawback policy. Their compensation includes significant equity awards, which are subject to vesting conditions and market performance. The company's ability to continue as a going concern directly impacts employee job security.
• **Creditors**: The company's ability to secure new financing and manage its existing debt (like the modified Ginkgo notes) is crucial for its solvency and ability to meet obligations to creditors. The proposed capital raises are intended to improve liquidity, which would benefit creditors.

Next Steps

• Hold the 2025 Annual Meeting of Stockholders on August 29, 2025, to vote on director elections, auditor ratification, and the Seneca and Ascent Issuance Proposals.
• Finalize definitive documentation for the Seneca Transaction with Southern Point Capital.
• Finalize definitive documentation for the Convertible Preferred Stock Offering and Equity Line of Credit Agreement with Ascent Partners Fund LLC.
• File a registration statement registering the resale of shares issuable upon conversion of Ascent Convertible Preferred Stock and exercise of Warrants within 30 days of closing, and use best efforts for effectiveness within 60 days.
• File one or more registration statements for the resale of common stock issued under the ELOC Agreement and Commitment Shares within 25 days of the ELOC Agreement execution, and use commercially reasonable efforts for effectiveness within 30 days.
• Golden Arrow Sponsor LLC to provide or organize $10 million in financing by August 13, 2025, or pay 75% of the excise tax liability if the IRS payment plan is denied.
• The Board expects to grant annual equity incentive awards during the first quarter of each fiscal year.

Key Dates

Recommendation

Keywords

SEC filing, Proxy Statement, Annual Meeting, Stockholder vote, Capital raise, Equity line of credit, Convertible preferred stock, Dilution, Going concern, Working capital, Corporate governance, Board of Directors, Executive compensation, Nasdaq listing rules, Excise tax liability, Related party transactions, Sustainable materials, Biotechnology